You searched for "Transplant" from the Body Image.

Stage	Phase	Principal Investigator	Study prefix	Study number	Title (click hyperlink for more information)
N/A	II/III	Philip McCarthy, MD	RP	98-15	Allogeneic Blood or Marrow Transplantation for Hematologic Malignancy and Aplastic Anemia
	III	Philip McCarthy, MD	NCG	84906	(BMT CTN 0402) A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as GVHD Prophylaxiz After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation
	II	Philip McCarthy, MD	I	72806	Autologous Blood and Marrow Transplantation for Hemotologic Malignancies and Selected Solid Tumors
	I/II	Philip McCarthy, MD	NCG	93306	(BMT CTN 301) Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation from HLA-Compatible Unrelated Donors in Severe Aplastic Anemia
	Lab Study	Kelvin Lee, MD	I	40404	Leukocyte Aphersis for Research
	II	Meir Wetzler, MD	NCG / CALGB	97406	(CALGB 10503) Phase II of Maintenance Therapy with Decitabine (NSC #127716, IND #50733) Following Standard Induction and Cytogenetic Risk-Adapted Intensification in Previously Untreated Patients with AML < 60 years
Recurrent or Persistent	II	Philip McCarthy, MD	I	00703	Cellular Infusions in Patients with Recurrent or Persistent Hematologic Malignancies after Allogeneic Stem Cell Transplant.
N/A	II	Meir Wetzler, MD	CALGB	C10001	A Phase II Trial of Sequential Chemotherapy, Imatinib Mesylate (Gleevec, ST1571) (NSC #716051, IND 61135), and Transplantation for Adults with Newly Diagnosed PH Acute Lymphoblastic Leukemia by the CALGB and SWOG
N/A	N/A	Philip McCarthy, MD	NCG	00403	The National Marrow Donor Program Research Database for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries
	II	Minoo Battiwalla, MD	I	111207	(RIC MPD-RC 101) Study of Fludarabine-Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis
	Pilot	Shannon Smiley, MD	I	96606	Chronic Graft Versus Host Disease (cGvHD) is a Major Factor Determining Long-Term Outcome and Quality of Life (QOL) Following Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Total number of Clinical Trials found: 11

Return to Search page